Direct ElectroPhysiology Imaging
Watch Video >
* Delphi-MD is not approved for commercial use in the United States;
* Delphi-MD is not approved for commercial use in the United States;
* Delphi-MD is not approved for commercial use in the United States;
Delphi·MD in Stroke and TBI
Evaluation of White Matter Integrity Utilizing the Delphi·MD System. Front Neurosci. 2020 Dec 21;14:589107.
Read More >Delphi·MD for Detection of Healthy VS Unhealthy Brain Ageing
Introducing a Novel Approach for Evaluation & Monitoring of Brain Health Across Life Span Using Direct Non-invasive Brain Network Electrophysiology. Front Aging Neurosci. 2019 Sep 9;11:248.
Read More >Delphi·MD in Parkinson’s Disease
A multimodal approach using TMS and EEG reveals neurophysiological changes in Parkinson’s disease, Parkinsonism & Related Disorders, Parkinsonism related dis. 2021 Jun 18 ; 89:28;
Read More >Delphi·MD as Early Dementia \ Alzheimer’s Biomarker
Brain Network Integrity Changes in Subjective Cognitive Decline, a Possible Physiological Biomarker of Dementia Journal: Fronti Neurology. 2021 July
Read More >Nov 14, 2022
Delphi-MD Breakthrough diagnostic technology promises to reduce healthcare burden by detecting brain abnormalities prior to symptoms, at the point of care
PRESS RELEASE PRESS RELEASE